The Enterprise Value as of November 2024 (TTM) for Amneal Pharmaceuticals, Inc. (AMRX) is 6.31B

According to Amneal Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.31B. This represents a change of 37.33% compared to the average of 4.59B of the last 4 quarters.

Amneal Pharmaceuticals, Inc. (AMRX) Historical Enterprise Value (quarterly & annually)

How has AMRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Amneal Pharmaceuticals, Inc. over the last ten years is 3.38B. The current 6.31B Enterprise Value has changed 18.58% with respect to the historical average. Over the past ten years (40 quarters), AMRX's Enterprise Value was at its highest in in the September 2018 quarter at 5.44B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Amneal Pharmaceuticals, Inc. (AMRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amneal Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amneal Pharmaceuticals, Inc. (AMRX) Average Enterprise Value

How has AMRX Enterprise Value performed in the past?

The current Enterprise Value of Amneal Pharmaceuticals, Inc. (AMRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Amneal Pharmaceuticals, Inc. (AMRX) Enterprise Value vs. Peers

How is AMRX’s Enterprise Value compared to its peers?

Amneal Pharmaceuticals, Inc.’s Enterprise Value is greater than Alkermes plc (4.63B), less than Neurocrine Biosciences, Inc. (12.62B), less than Intra-Cellular Therapies, Inc. (8.64B), greater than Deciphera Pharmaceuticals, Inc. (2.15B), greater than Dynavax Technologies Corporation (1.76B), greater than Amphastar Pharmaceuticals, Inc. (2.62B), greater than Collegium Pharmaceutical, Inc. (1.80B), greater than Ironwood Pharmaceuticals, Inc. (677.16M), greater than ANI Pharmaceuticals, Inc. (1.68B), greater than Phibro Animal Health Corporation (1.20B), greater than Procaps Group S.A. (376.16M), greater than Silver Spike Investment Corp. (33.56M), greater than Eagle Pharmaceuticals, Inc. (24.78M), greater than Evolus, Inc. (721.48M), greater than Agile Therapeutics, Inc. (7.87M), greater than Assertio Holdings, Inc. (91.56M), greater than AcelRx Pharmaceuticals, Inc. (1.19M), greater than Lifecore Biomedical, Inc. (400.55M),

Build a custom stock screener for Amneal Pharmaceuticals, Inc. (AMRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amneal Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amneal Pharmaceuticals, Inc. (AMRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amneal Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.